Publications

• Activity of pemetrexed in recurrent, metastatic sacral chordoma

  Current Problems in Cancer: Case Reports Mar 2025
  1. Dominique G. Celestino
  2. Lara E. Davis
  3. Santosh Kesari

• CSF1R Inhibition in Patients with Advanced Solid Tumors or Tenosynovial Giant Cell Tumor

  Clinical Cancer Research Sep 15, 2024
  1. Hans Gelderblom
  2. Albiruni A. Razak
  3. Matthew H. Taylor
  4. Todd M. Bauer
  5. Breelyn Wilky
  6. Javier Martin-Broto
  7. Alejandro F. Gonzalez
  8. Piotr Rutkowski
  9. Bartlomiej Szostakowski
  10. Thierry Alcindor
  11. Ramy Saleh
  12. Sofia Genta
  13. Silvia Stacchiotti
  14. Michiel van de Sande
  15. Andrew J. Wagner
  16. Nicholas Bernthal
  17. Lara E. Davis
  18. Jacqueline Vuky
  19. Christopher Tait
  20. Bahar Matin
  21. Supraja Narasimhan
  22. Maitreyi G. Sharma
  23. Rodrigo Ruiz-Soto
  24. Matthew L. Sherman
  25. William D. Tap

• Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma

  Journal of Clinical Oncology Nov 1, 2024
  1. Paul A. Meyers
  2. Noah Federman
  3. Najat Daw
  4. Peter M. Anderson
  5. Lara E. Davis
  6. Ae Rang Kim
  7. Margaret E. Macy
  8. Angela Pietrofeso
  9. Ravin Ratan
  10. Richard F. Riedel
  11. Matteo Trucco
  12. James B. Breitmeyer
  13. Jeffrey A. Toretsky
  14. Joseph A. Ludwig

• Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032)

  The Lancet Nov 23, 2024
  1. Yvonne M. Mowery
  2. Karla V. Ballman
  3. Angela M. Hong
  4. Scott M. Schuetze
  5. Andrew J. Wagner
  6. Varun Monga
  7. Rachel S. Heise
  8. Steven Attia
  9. Edwin Choy
  10. Melissa A. Burgess
  11. Susie Bae
  12. David I. Pryor
  13. Brian A. Van Tine
  14. Gabriel Tinoco
  15. Bartosz Chmielowski
  16. Carolyn Freeman
  17. Alessandro Gronchi
  18. Christian F. Meyer
  19. Mark A. Dickson
  20. Lee Hartner
  21. Lara E. Davis
  22. Benjamin C. Powers
  23. Everett J. Moding
  24. Kent J. Weinhold
  25. Matt van de Rijn
  26. Brian E. Brigman
  27. Richard F. Riedel
  28. David G. Kirsch

• Single nucleotide variants in nuclear pore complex disassembly pathway associated with poor survival in osteosarcoma

  Frontiers in Genetics Mar 2024
  1. James E. Jacobs
  2. Lara Davis
  3. Shannon McWeeney

• A phase II trial of regorafenib in patients with advanced Ewing sarcoma and related tumors of soft tissue and bone

  Cancer medicine 2022
  1. Steven Attia
  2. Vanessa Bolejack
  3. Kristen N. Ganjoo
  4. Suzanne George
  5. Mark Agulnik
  6. Daniel Rushing
  7. Elizabeth T. Loggers
  8. Michael B. Livingston
  9. Jennifer Wright
  10. Sant P. Chawla
  11. Scott H. Okuno
  12. Denise K. Reinke
  13. Richard F. Riedel
  14. Lara E. Davis
  15. Christopher W. Ryan
  16. Robert G. Maki

• Intraosseous Spindle Cell Rhabdomyosarcoma with MEIS1::NCOA2 Fusion–Case Report with Substantial Clinical Follow-up and Review of the Literature

  Cancer Investigation 2023
  1. Benjamin F. Smith
  2. Yee Cheen Doung
  3. Brooke Beckett
  4. Christopher L. Corless
  5. Lara E. Davis
  6. Jessica L. Davis

• Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.

  New England Journal of Medicine 2023
  1. Mrinal Gounder
  2. Ravin Ratan
  3. Thierry Alcindor
  4. Patrick Schöffski
  5. Winette T. Van Der Graaf
  6. Breelyn A. Wilky
  7. Richard F. Riedel
  8. Allison Lim
  9. L. Mary Smith
  10. Stephanie Moody
  11. Steven Attia
  12. Sant Chawla
  13. Gina D'Amato
  14. Noah Federman
  15. Priscilla Merriam
  16. Brian A. Van Tine
  17. Bruno Vincenzi
  18. Charlotte Benson
  19. Nam Quoc Bui
  20. Rashmi Chugh
  21. Gabriel Tinoco
  22. John Charlson
  23. Palma Dileo
  24. Lee Hartner
  25. Lore Lapeire
  26. Filomena Mazzeo
  27. Emanuela Palmerini
  28. Peter Reichardt
  29. Silvia Stacchiotti
  30. Howard H. Bailey
  31. Melissa A. Burgess
  32. Gregory M. Cote
  33. Lara E. Davis
  34. Hari Deshpande
  35. Hans Gelderblom
  36. Giovanni Grignani
  37. Elizabeth Loggers
  38. Tony Philip
  39. Joseph G. Pressey
  40. Shivaani Kummar
  41. Bernd Kasper

• Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation

  Cold Spring Harbor Molecular Case Studies Jan 2022
  1. Florence Choo
  2. Igor Odintsov
  3. Kevin Nusser
  4. Katelyn S. Nicholson
  5. Lara Davis
  6. Christopher L. Corless
  7. Linda Stork
  8. Romel Somwar
  9. Marc Ladanyi
  10. Jessica L. Davis
  11. Monika A. Davare

• Identified Enrollment Challenges of Adolescent and Young Adult Patients on the Nonchemotherapy Arm of Children's Oncology Group Study ARST1321

  Journal of Adolescent and Young Adult Oncology Jun 1, 2022
  1. Viswatej Avutu
  2. Aaron R. Weiss
  3. Damon R. Reed
  4. Safia K. Ahmed
  5. Wendy A. Allen-Rhoades
  6. Yen Lin E. Chen
  7. Lara E. Davis
  8. Bree R. Eaton
  9. Douglas S. Hawkins
  10. Danny J. Indelicato
  11. Shreyaskumar R. Patel
  12. R. Lor Randall
  13. Denise K. Reinke
  14. Richard F. Riedel
  15. Thomas J. Scharschmidt
  16. Katherine A. Thornton
  17. Dian Wang
  18. Katherine A. Janeway
  19. Lisa M. Kopp

• Pregnancy outcomes related to the treatment of sarcomas with anthracyclines and/or ifosfamide during pregnancy

  Cancer medicine 2022
  1. Devon Miller
  2. John A. Livingston
  3. Yeonhee Park
  4. Kristi Posey
  5. Sonia Godbole
  6. Keith Skubitz
  7. Steven I. Robinson
  8. Mark Agulnik
  9. Lara E Davis
  10. Brian A. Van Tine
  11. Angela C. Hirbe
  12. Amanda Parkes

• Protein arginine methyltransferase 5 is essential for oncogene product EWSR1-ATF1-mediated gene transcription in clear cell sarcoma

  Journal of Biological Chemistry Oct 2022
  1. Bingbing X. Li
  2. Larry L. David
  3. Lara E. Davis
  4. Xiangshu Xiao

• GAB1-ABL1 fusions in tumors that have histologic overlap with NTRK-rearranged spindle cell tumors

  Genes Chromosomes and Cancer 2021
  1. Florence Choo
  2. Dinesh Rakheja
  3. Lara E. Davis
  4. Monika Davare
  5. Jason Y. Park
  6. Charles F. Timmons
  7. Tanaya Neff
  8. Carol Beadling
  9. Christopher L. Corless
  10. Jessica L. Davis

• Primary aortic angiosarcoma

  Radiology: Cardiothoracic Imaging Aug 2021
  1. Case H. Keltner
  2. Ana Paula Santos Lima
  3. Malinda West
  4. Kenneth R. Gundle
  5. Cristina Fuss
  6. Lara E. Davis

• Vimseltinib

  Molecular cancer therapeutics Nov 2021
  1. Bryan D. Smith
  2. Michael D. Kaufman
  3. Scott C. Wise
  4. Yu Mi Ahn
  5. Timothy M. Caldwell
  6. Cynthia B. Leary
  7. Wei Ping Lu
  8. Gege Tan
  9. Lakshminarayana Vogeti
  10. Subha Vogeti
  11. Breelyn A. Wilky
  12. Lara E. Davis
  13. Maitreyi Sharma
  14. Rodrigo Ruiz-Soto
  15. Daniel L. Flynn

• A Randomized, Double-Blind, Placebo-Controlled, Phase II Study of Regorafenib Versus Placebo in Advanced/Metastatic, Treatment-Refractory Liposarcoma

  Oncologist 2020
  1. Richard F. Riedel
  2. Karla V. Ballman
  3. Yao Lu
  4. Steven Attia
  5. Elizabeth T. Loggers
  6. Kristen N. Ganjoo
  7. Michael B. Livingston
  8. Warren Chow
  9. Jennifer Wright
  10. John H. Ward
  11. Daniel Rushing
  12. Scott H. Okuno
  13. Damon R. Reed
  14. David A. Liebner
  15. Vicki L. Keedy
  16. Leo Mascarenhas
  17. Lara E. Davis
  18. Christopher Ryan
  19. Denise K. Reinke
  20. Robert G. Maki

• Correlative analyses of the SARC028 trial reveal an association between sarcoma-associated immune infiltrate and response to pembrolizumab

  Clinical Cancer Research Mar 15, 2020
  1. Emily Z. Keung
  2. Melissa Burgess
  3. Ruth Salazar
  4. Edwin R. Parra
  5. Jaime Rodrigues-Canales
  6. Vanessa Bolejack
  7. Brian A. Van Tine
  8. Scott M. Schuetze
  9. Steven Attia
  10. Richard F. Riedel
  11. James Hu
  12. Scott H. Okuno
  13. Dennis A. Priebat
  14. Sujana Movva
  15. Lara E. Davis
  16. Damon R. Reed
  17. Alexandre Reuben
  18. Christina L. Roland
  19. Denise Reinke
  20. Alexander J. Lazar
  21. Wei Lien Wang
  22. Jennifer A. Wargo
  23. Hussein A. Tawbi

• Feasibility of Treating Adults with Ewing or Ewing-Like Sarcoma with Interval-Compressed Vincristine, Doxorubicin, and Cyclophosphamide Alternating with Ifosfamide and Etoposide

  Oncologist Jan 1, 2019
  1. Eric Lu
  2. Christopher W. Ryan
  3. Solange Bassale
  4. Jeong Youn Lim
  5. Lara E. Davis

• Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1

  The Lancet Oncology Nov 2020
  1. Mrinal Gounder
  2. Patrick Schöffski
  3. Robin L. Jones
  4. Mark Agulnik
  5. Gregory M. Cote
  6. Victor M. Villalobos
  7. Steven Attia
  8. Rashmi Chugh
  9. Tom Wei Wu Chen
  10. Thierry Jahan
  11. Elizabeth T. Loggers
  12. Abha Gupta
  13. Antoine Italiano
  14. George D. Demetri
  15. Ravin Ratan
  16. Lara E. Davis
  17. Olivier Mir
  18. Palma Dileo
  19. Brian A. Van Tine
  20. Joseph G. Pressey
  21. Trupti Lingaraj
  22. Anand Rajarethinam
  23. Laura Sierra
  24. Shefali Agarwal
  25. Silvia Stacchiotti

• Discovery and characterization of recurrent, targetable ALK fusions in leiomyosarcoma

  Molecular Cancer Research Mar 1, 2019
  1. Lara E. Davis
  2. Kevin D. Nusser
  3. Joanna Przybyl
  4. Janet Pittsenbarger
  5. Nicolle E. Hofmann
  6. Sushama Varma
  7. Sujay Vennam
  8. Maria Debiec-Rychter
  9. Matt van de Rijn
  10. Monika A. Davare

• Probabilistic modeling of personalized drug combinations from integrated chemical screen and molecular data in sarcoma

  BMC cancer Jun 17, 2019
  1. Noah E. Berlow
  2. Rishi Rikhi
  3. Mathew Geltzeiler
  4. Jinu Abraham
  5. Matthew N. Svalina
  6. Lara E. Davis
  7. Erin Wise
  8. Maria Mancini
  9. Jonathan Noujaim
  10. Atiya Mansoor
  11. Michael J. Quist
  12. Kevin L. Matlock
  13. Martin W. Goros
  14. Brian S. Hernandez
  15. Yee C. Doung
  16. Khin Thway
  17. Tomohide Tsukahara
  18. Jun Nishio
  19. Elaine T. Huang
  20. Susan Airhart
  21. Carol J. Bult
  22. Regina Gandour-Edwards
  23. Robert G. Maki
  24. Robin L. Jones
  25. Joel E. Michalek
  26. Milan Milovancev
  27. Souparno Ghosh
  28. Ranadip Pal
  29. Charles Keller

• Randomized double-blind phase II study of regorafenib in patients with metastatic osteosarcoma

  Journal of Clinical Oncology 2019
  1. Lara E. Davis
  2. Vanessa Bolejack
  3. Christopher W. Ryan
  4. Kristen N. Ganjoo
  5. Elizabeth T. Loggers
  6. Sant Chawla
  7. Mark Agulnik
  8. Michael B. Livingston
  9. Damon Reed
  10. Vicky Keedy
  11. Daniel Rushing
  12. Scott Okuno
  13. Denise K. Reinke
  14. Richard F. Riedel
  15. Steven Attia
  16. Leo Mascarenhas
  17. Robert G. Maki

• Safety and efficacy of high-dose methotrexate for osteosarcoma in adolescents compared with young adults

  Cancer medicine Jan 1, 2018
  1. Brittany Wippel
  2. Kenneth R. Gundle
  3. Theresa Dang
  4. Jillian Paxton
  5. Joseph Bubalo
  6. Linda Stork
  7. Rongwei Fu
  8. Christopher W. Ryan
  9. Lara E. Davis

• Epirubicin and Ifosfamide with Preoperative Radiation for High-Risk Soft Tissue Sarcomas

  Annals of surgical oncology Apr 1, 2018
  1. Eric Lu
  2. Kelly S. Perlewitz
  3. James B. Hayden
  4. Arthur Y. Hung
  5. Yee Cheen Doung
  6. Lara E. Davis
  7. Atiya Mansoor
  8. John T. Vetto
  9. Kevin Billingsley
  10. Andy Kaempf
  11. Byung Park
  12. Christopher W. Ryan